More children with neurofibromatosis type 1 (NF1) develop brain tumors than researchers previously believed, according to new research published in Neurology: Clinical Practice.
MIT researchers are using an artificial intelligence (AI) model that would help determine the correct drug dosage and, in turn, reduce debilitating side effects for brain cancer patients.
Developing type 1 diabetes before the age of 10 shortens the lifespans of women by almost 18 years and of men by about 14 years, according to a Swedish registry study published in The Lancet.
Jack W. Jennings, MD, PhD, has been named the new chief of musculoskeletal radiology at the Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis.
On Aug. 9, the FDA expanded its list of valsartan products currently under recall to include other items that contain the active ingredient, which may be tainted with a carcinogenic impurity, manufactured by Hetero Labs Limited in India.
At Tuscaloosa’s DCH Regional Medical Center in Alabama, nurses are utilizing the latest imaging technology to create digital footprints of a newborn, WBRC Fox 6 News reports.
A machine-learning algorithm that uses a technique known as reinforced learning can dramatically cut toxic chemotherapy and radiotherapy by optimizing treatment plans and drug dosages for glioblastoma patients, according to research out of the Massachusetts Institute of Technology.
